The Eph receptors are the largest family of tyrosine kinase and play a primary role in tissue differentiation during embryogenesis. Since its discovery, the Eph-ephrin system has been extensively studied for its role in physiology and pathology in the adult as well. A number of evidence has correlated deregulation of the Eph-ephrin system in cancer and tumor blood vessels to a poor prognosis. Moreover, the Eph-ephrin system modulates glucose balance and synaptic connections plasticity. Taken together, these data highlight an important role of the Eph-ephrin system in pathological processes, and the opportunity of targeting this system for therapy. Different tools have been developed to modulate Eph receptor and ephrin activity in different pathological processes. In fact, Eph kinase inhibition appear to be useful for tumor angiogenesis whereas stimulation could be suitable in tumors where Akt is activated. Finally, diabetes therapy could take advantage of ephrin reverse signaling activation.
